Preparation method of spinal cord subacute combined degeneration model

A subacute and degenerative disease technology, applied in the field of medical biology, can solve problems such as insufficient vitamin B content, inability to complete vitamin B intake, and expensive transgenic mice, etc., to reduce research costs, low prices, and increase the speed of preparation Effect

Active Publication Date: 2022-04-29
王涛
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The existing animal model of subacute combined degeneration of the spinal cord is prepared as follows: through manipulation at the genetic level, the mice cannot complete the vitamin B 12 intake, thus making vitamin B in mice 12 Subacute combined degeneration of the spinal cord
However, the transgenic mice used in this preparation method are expensive and are not sold in China. At the same time, considering that the preparation cycle is about two months, this preparation method has the disadvantages of long preparation time and high preparation cost.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of spinal cord subacute combined degeneration model
  • Preparation method of spinal cord subacute combined degeneration model
  • Preparation method of spinal cord subacute combined degeneration model

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] Embodiment 1: the preparation method of spinal cord subacute combined degenerative disease model, the method comprises the following steps:

[0026] S1. Dilute 10 μl of hexachlorobutadiene into 490ul of edible oil, which is corn oil in this embodiment;

[0027] S2. According to the dose of 50-250 μl / mouse, the mice are given intragastric or intraperitoneal injection, and the mice are normally fed during the medication period;

[0028] S3. Perform intragastric or intraperitoneal injection again at an interval of 48 hours, for a total of three administrations;

[0029] S4. Test the mice 24 hours after the third administration, and observe whether there are clinical symptoms of subacute combined degeneration of the spinal cord:

[0030] S4.1, the body weight of mice is tested and recorded every 24 hours during the medication period;

[0031] S4.2. Conduct behavioral evaluation on mice, including but not limited to: gait, pole climbing, rotarod and wire grid experiments; ...

Embodiment 2

[0033] Embodiment 2: Group A of test mice, a group of 10, carried out the following operations to it:

[0034] S1. Dilute 10 μl of hexachlorobutadiene into 490 μl of corn oil;

[0035] S2. According to the dose of 50 μl / mouse, the mice were given intragastric or intraperitoneal injection, and the mice were normally fed during the medication period;

[0036] S3. Perform intragastric or intraperitoneal injection again at an interval of 48 hours, for a total of three administrations;

[0037] S4. Test the mice 24 hours after the third administration, and observe whether there are clinical symptoms of subacute combined degeneration of the spinal cord:

[0038] S4.1, the body weight of mice is tested and recorded every 24 hours during the medication period;

[0039] S4.2. Conduct behavioral evaluation on mice, including but not limited to: gait, pole climbing, rotarod and wire grid experiments;

[0040] S4.3. Measurement of serum vitamin B in mice 12 content.

Embodiment 3

[0041] Embodiment 3: Group B of test mice, a group of 10, carried out the following operations to it:

[0042] S1. Dilute 10 μl of hexachlorobutadiene into 490 μl of corn oil;

[0043] S2. According to the dose of 150 μl / mouse, the mice were given intragastric or intraperitoneal injection, and the mice were fed normally during the medication period;

[0044] S3. Perform intragastric or intraperitoneal injection again at an interval of 48 hours, for a total of three administrations;

[0045] S4. Test the mice 24 hours after the third administration, and observe whether there are clinical symptoms of subacute combined degeneration of the spinal cord:

[0046] S4.1, the body weight of mice is tested and recorded every 24 hours during the medication period;

[0047] S4.2. Conduct behavioral evaluation on mice, including but not limited to: gait, pole climbing, rotarod and wire grid experiments;

[0048] S4.3. Measurement of serum vitamin B in mice 12 content.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a preparation method of a spinal cord subacute combined degenerative disease model, which comprises diluting 10 μl of hexachlorobutadiene into 490 μl of corn oil; according to the dose of 150-250 μl / mouse, intragastric or intraperitoneal administration of the mice Injection, normal feeding during the medication period; intragastric or intraperitoneal injection again at intervals of 48 hours, a total of three administrations; tests on mice to observe whether clinical symptoms of subacute combined degenerative disease of the spinal cord appear, including the following methods: Medication During the period, the weight of the mice was tested and recorded every 24 hours, and the behavioral evaluation of the mice was carried out, including but not limited to: gait, pole climbing, rotating rod and wire grid experiments, and the mice were measured after the medication was completed. serum vitamin B 12 content. Through the above settings, the preparation method of the spinal cord subacute combined degenerative disease model can be completed within 6 days using HCBD, and because the price of HCBD is low, the preparation method of the present application has advantages compared with the traditional preparation method. Advantages of high speed and low cost.

Description

technical field [0001] The invention relates to the technical field of medical biology, in particular to a method for preparing a spinal cord subacute combined degenerative disease model. Background technique [0002] Subacute combined degeneration of the spinal cord, referred to as subacute combined degeneration, is due to vitamin B 12 Impaired intake, absorption, binding, transport, or metabolism of B vitamins in the body 12 Diseases of central and peripheral nervous system degeneration caused by insufficient content. The lesions mainly involve the dorsal cord, lateral cord, and peripheral nerves. The clinical manifestations are deep sensory loss of the lower extremities, sensory ataxia, spastic paralysis, and peripheral neuropathy, often accompanied by clinical signs of anemia. [0003] In order to better study the subacute combined degeneration of the spinal cord, it is necessary to establish corresponding animal models. Animal disease models are mainly used in experi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A01K67/02A61D7/00
CPCA01K67/02A61D7/00
Inventor 孙雅迪韩超徐岩黄金莎熊念王涛
Owner 王涛
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products